PHILADELPHIA — After undergoing breast lift surgery (mastopexy), women may find themselves wearing a smaller bra—with an average decrease of one bra cup size, reports a study in the July issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS).
But the difference reflects the effects of the breast lift itself, rather than a true reduction in breast size, according to the study by Dr. Katie Elizabeth Weichman of New York University and colleagues. They believe their results have important implications for talking to patients about the expected results after breast lift surgery.
After Breasts Are Lifted, Cup Size Goes Down
Mastopexy is a popular cosmetic surgery procedure, performed in nearly 90,000 US women in 2012, according to ASPS statistics. Breast lift surgery restores a more youthful and lifted appearance in women with sagging (ptosis) of the breasts due to aging, pregnancy and breastfeeding, etc.
The researchers performed a follow-up survey of 20 women who underwent mastopexy at an average age of 47 years. All patients underwent breast-lifting only—that is, with no significant breast reduction or augmentation. Five years later, the women were asked about their bra cup size before versus after breast lift surgery. Weight change and other factors that might affect bra fit were evaluated as well.
The women reported an average decrease of approximately one cup size—for example, from a D to a C cup. All of the women reported no change in bra manufacturer; that's an important consideration, as sizing can differ between brands.
One patient reported a substantial increase in cup size, but this seemed to be related to hormone therapy and weight gain. All of the women said they were satisfied with the results of their breast lift surgery.
After Mastopexy, Bra Fit Is Closer to 'True' Cup Size
So if surgery only lifted the breasts rather without changing their size, why did cup size decrease? The answer has to do with correct bra fit and patient comfort, Dr. Weichman and coauthors believe. "It is well known that most women do not wear the correct bra size," they write.
Because of excess skin and soft tissue, women with breast ptosis may be more comfortable with a looser-fitting bra. The researchers write, "It is our contention that ptotic breast fills out a larger (than actual) brassiere cup size." After their breasts have been lifted, women may choose a smaller cup size for reasons of comfort.
The findings have important implications for setting patient expectations—especially because most patients considering mastopexy want to improve the shape of their breasts, without changing the size. "Consequently, conveying to them at the initial visit, that lifting alone will result in a smaller cup size avoids the potential for over reducing and patient dissatisfaction," Dr. Weichman and coauthors write.
"We encourage patients to consider their true preoperative cup size to be smaller than what they currently wear," the authors add. They suggest a technique that the plastic surgeon can use—simply elevating the breast with the thumb and forefinger—to give women an idea of the expected results after mastopexy, as well as showing them their true bra cup size.
Dr. Weichman and colleagues note that their patients were on average of low-normal body weight and wore at least a C cup size before surgery. The findings therefore may not apply to heavier women or those with smaller breasts.
Plastic and Reconstructive Surgery is published by Lippincott Williams & Wilkins, part of Wolters Kluwer Health.
About Wolters Kluwer
Wolters Kluwer (WKL) is a global leader in professional information, software solutions and services for the clinicians, nurses, accountants, lawyers and tax, finance, audit, risk, compliance and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.
Wolters Kluwer reported 2020 annual revenues of €4.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,200 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.
Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes across healthcare. We support clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions. For more information about our solutions, visit //www.wolterskluwer.com/en/health and follow us on LinkedIn and Twitter @WKHealth.
For more information, visit www.wolterskluwer.com, and follow us on Twitter, Facebook, LinkedIn and YouTube.